Assessment of breast pathologies using nonlinear microscopy YK Tao, D Shen, Y Sheikine, OO Ahsen, HH Wang, DB Schmolze, ... Proceedings of the National Academy of Sciences 111 (43), 15304-15309, 2014 | 229 | 2014 |
Connecting blood and intratumoral Treg cell activity in predicting future relapse in breast cancer L Wang, DL Simons, X Lu, TY Tu, S Solomon, R Wang, A Rosario, ... Nature immunology 20 (9), 1220-1230, 2019 | 174 | 2019 |
Transformer-based biomarker prediction from colorectal cancer histology: A large-scale multicentric study SJ Wagner, D Reisenbüchler, NP West, JM Niehues, J Zhu, S Foersch, ... Cancer Cell 41 (9), 1650-1661. e4, 2023 | 119 | 2023 |
Comprehensive profiling of poor-risk paired primary and recurrent triple-negative breast cancers reveals immune phenotype shifts KE Hutchinson, SE Yost, CW Chang, RM Johnson, AR Carr, PR McAdam, ... Clinical Cancer Research 26 (3), 657-668, 2020 | 105 | 2020 |
Raman spectroscopy for rapid evaluation of surgical margins during breast cancer lumpectomy WC Zúñiga, V Jones, SM Anderson, A Echevarria, NL Miller, C Stashko, ... Scientific reports 9 (1), 14639, 2019 | 91 | 2019 |
Advances in microscopy techniques DB Schmolze, C Standley, KE Fogarty, AH Fischer Archives of pathology & laboratory medicine 135 (2), 255-263, 2011 | 82 | 2011 |
Artificial intelligence for detection of microsatellite instability in colorectal cancer—a multicentric analysis of a pre-screening tool for clinical application A Echle, NG Laleh, P Quirke, HI Grabsch, HS Muti, OL Saldanha, ... ESMO open 7 (2), 100400, 2022 | 79 | 2022 |
EMDomics: a robust and powerful method for the identification of genes differentially expressed between heterogeneous classes S Nabavi, D Schmolze, M Maitituoheti, S Malladi, AH Beck Bioinformatics 32 (4), 533-541, 2016 | 75 | 2016 |
Characterization and analysis of the composition and dynamics of the mammalian riboproteome M Reschke, JG Clohessy, N Seitzer, DP Goldstein, SB Breitkopf, ... Cell reports 4 (6), 1276-1287, 2013 | 70 | 2013 |
A phase II clinical trial of pembrolizumab and enobosarm in patients with androgen receptor‐positive metastatic triple‐negative breast cancer Y Yuan, JS Lee, SE Yost, PH Frankel, C Ruel, CA Egelston, W Guo, ... The oncologist 26 (2), 99-e217, 2021 | 68 | 2021 |
Phase I/II trial of palbociclib, pembrolizumab and letrozole in patients with hormone receptor-positive metastatic breast cancer Y Yuan, JS Lee, SE Yost, PH Frankel, C Ruel, CA Egelston, W Guo, ... European Journal of Cancer 154, 11-20, 2021 | 66 | 2021 |
Direct comparison between confocal and multiphoton microscopy for rapid histopathological evaluation of unfixed human breast tissue T Yoshitake, MG Giacomelli, LC Cahill, DB Schmolze, H Vardeh, ... Journal of biomedical optics 21 (12), 126021-126021, 2016 | 52 | 2016 |
Crowdsourcing scoring of immunohistochemistry images: Evaluating performance of the crowd and an automated computational method H Irshad, EY Oh, D Schmolze, LM Quintana, L Collins, RM Tamimi, ... Scientific reports 7 (1), 43286, 2017 | 44 | 2017 |
Identification of tissue-specific DNA methylation signatures for thyroid nodule diagnostics JH Yim, AH Choi, AX Li, H Qin, S Chang, SWT Tong, P Chu, BW Kim, ... Clinical Cancer Research 25 (2), 544-551, 2019 | 40 | 2019 |
Phase I clinical trial of the combination of eribulin and everolimus in patients with metastatic triple-negative breast cancer JS Lee, SE Yost, S Blanchard, D Schmolze, HH Yin, R Pillai, K Robinson, ... Breast Cancer Research 21, 1-13, 2019 | 39 | 2019 |
Raman spectroscopy and artificial intelligence to predict the Bayesian probability of breast cancer R Kothari, V Jones, D Mena, V Bermúdez Reyes, Y Shon, JP Smith, ... Scientific reports 11 (1), 6482, 2021 | 38 | 2021 |
Towards integration of 64Cu-DOTA-trastuzumab PET-CT and MRI with mathematical modeling to predict response to neoadjuvant therapy in HER2 + breast cancer AM Jarrett, DA Hormuth, V Adhikarla, P Sahoo, D Abler, L Tumyan, ... Scientific reports 10 (1), 20518, 2020 | 38 | 2020 |
Mutation and immune profiling of metaplastic breast cancer: correlation with survival M Afkhami, D Schmolze, SE Yost, PH Frankel, A Dagis, IU Amanam, ... PLoS One 14 (11), e0224726, 2019 | 38 | 2019 |
Phase II Trial of Neoadjuvant Carboplatin and Nab‐Paclitaxel in Patients with Triple‐Negative Breast Cancer Y Yuan, JS Lee, SE Yost, SM Li, PH Frankel, C Ruel, D Schmolze, ... The Oncologist 26 (3), e382-e393, 2021 | 35 | 2021 |
Accuracy of gross intraoperative margin assessment for breast cancer: experience since the SSO-ASTRO margin consensus guidelines A Nunez, V Jones, K Schulz-Costello, D Schmolze Scientific Reports 10 (1), 17344, 2020 | 34 | 2020 |